PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 34.29 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $94.498 million which beat the analyst consensus estimate of $92.893 million by 1.73 percent. This is a 19.34 percent increase over sales of $79.182 million the same period last year.